In June 2024, the U.S. Food and Drug Administration (FDA) approved the first chewable tablets developed to help manage urinary incontinence in dogs caused by urethral sphincter hypotonus. Produced by ...
MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on ADHD, pain, addiction and neurological disorders, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results